Translocation of arrestin induced by human A3 adenosine receptor ligands in an engineered cell line: Comparison with G protein-dependent pathways
- 30 April 2008
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 57 (4) , 303-311
- https://doi.org/10.1016/j.phrs.2008.02.008
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Internalization and desensitization of adenosine receptorsPurinergic Signalling, 2007
- The anti-inflammatory effect of A3adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritisExpert Opinion on Investigational Drugs, 2007
- Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK ActivationJournal of Biological Chemistry, 2007
- β-Arrestin-biased ligands at seven-transmembrane receptorsTrends in Pharmacological Sciences, 2007
- β-Arrestins and Cell SignalingAnnual Review of Physiology, 2007
- Structure−Activity Relationships of New 1H-Imidazo[4,5-c]quinolin-4-amine Derivatives as Allosteric Enhancers of the A3Adenosine ReceptorJournal of Medicinal Chemistry, 2006
- Orthogonal Activation of the Reengineered A3Adenosine Receptor (Neoceptor) Using Tailored Nucleoside AgonistsJournal of Medicinal Chemistry, 2006
- Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moietyBioorganic & Medicinal Chemistry Letters, 2006
- New Concepts in Drug Discovery: Collateral Efficacy and Permissive AntagonismNature Reviews Drug Discovery, 2005
- Cell-Based High-Throughput Screening Assay System for Monitoring G Protein-Coupled Receptor Activation Using β-Galactosidase Enzyme Complementation TechnologySLAS Discovery, 2002